Bilaketaren emaitzak - Paul Angulo

Findu emaitzak
  1. 1
    GI Epidemiology: nonalcoholic fatty liver disease

    GI Epidemiology: nonalcoholic fatty liver disease nork Paul Angulo

    Argitaratua 2007
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  2. 2
    Long-term mortality in nonalcoholic fatty liver disease: Is liver histology of any prognostic significance?

    Long-term mortality in nonalcoholic fatty liver disease: Is liver histology of any prognostic significance? nork Paul Angulo

    Argitaratua 2010
    Testu osoa
    Carta
    Gogokoenen artean sartu
    Gorde:
  3. 3
    Diagnosing steatohepatitis and predicting liver‐related mortality in patients with NAFLD: Two distinct concepts

    Diagnosing steatohepatitis and predicting liver‐related mortality in patients with NAFLD: Two distinct concepts nork Paul Angulo

    Argitaratua 2011
    Testu osoa Testu osoa
    Carta
    Gogokoenen artean sartu
    Gorde:
  4. 4
    NAFLD, Obesity, and Bariatric Surgery

    NAFLD, Obesity, and Bariatric Surgery nork Paul Angulo

    Argitaratua 2006
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  5. 5
    Nonalcoholic fatty liver disease and liver transplantation

    Nonalcoholic fatty liver disease and liver transplantation nork Paul Angulo

    Argitaratua 2006
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  6. 6
    Treatment of nonalcoholic fatty liver disease

    Treatment of nonalcoholic fatty liver disease nork Paul Angulo

    Argitaratua 2002
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  7. 7
    Can Nash Be Diagnosed, Graded, and Staged Noninvasively?

    Can Nash Be Diagnosed, Graded, and Staged Noninvasively? nork Garfield A. Grandison, Paul Angulo

    Argitaratua 2012
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  8. 8
    Treatment of non-alcoholic fatty liver disease

    Treatment of non-alcoholic fatty liver disease nork Leon A. Adams, Paul Angulo

    Argitaratua 2006
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  9. 9
    Primary sclerosing cholangitis

    Primary sclerosing cholangitis nork Paul Angulo, Keith D. Lindor

    Argitaratua 1999
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  10. 10
    Prevalence and predictors of esophageal varices in patients with primary sclerosing cholangitis

    Prevalence and predictors of esophageal varices in patients with primary sclerosing cholangitis nork Claudia O. Zein, Keith D. Lindor, Paul Angulo

    Argitaratua 2004
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  11. 11
    Nonalcoholic fatty liver disease

    Nonalcoholic fatty liver disease nork Leon A. Adams, Paul Angulo, Keith D. Lindor

    Argitaratua 2005
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  12. 12
    Small-duct primary sclerosing cholangitis: A long-term follow-up study

    Small-duct primary sclerosing cholangitis: A long-term follow-up study nork Paul Angulo, Yaakov Maor‐Kendler, Keith D. Lindor

    Argitaratua 2002
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  13. 13
    Nonalcoholic fatty liver disease: A precursor of the metabolic syndrome

    Nonalcoholic fatty liver disease: A precursor of the metabolic syndrome nork Amedeo Lonardo, Stefano Ballestri, Giulio Marchesini, Paul Angulo, Paola Loria

    Argitaratua 2014
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  14. 14
    Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis

    Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis nork Paul Angulo, Jill C. Keach, Kenneth P. Batts, Keith D. Lindor

    Argitaratua 1999
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  15. 15
    Prevalence and Indicators of Portal Hypertension in Patients With Nonalcoholic Fatty Liver Disease

    Prevalence and Indicators of Portal Hypertension in Patients With Nonalcoholic Fatty Liver Disease nork Flavia Mendes, Ayako Suzuki, Schuyler O. Sanderson, Keith D. Lindor, Paul Angulo

    Argitaratua 2012
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  16. 16
    Cost-minimization analysis of MRC versus ERCP for the diagnosis of primary sclerosing cholangitis

    Cost-minimization analysis of MRC versus ERCP for the diagnosis of primary sclerosing cholangitis nork Jayant A. Talwalkar, Paul Angulo, Daniel C. Johnson, Bret T. Petersen, Keith D. Lindor

    Argitaratua 2004
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  17. 17
    Silymarin in the Treatment of Patients With Primary Biliary Cirrhosis With a Suboptimal Response to Ursodeoxycholic Acid

    Silymarin in the Treatment of Patients With Primary Biliary Cirrhosis With a Suboptimal Response to Ursodeoxycholic Acid nork Paul Angulo, Tushar Patel, Roberta A. Jorgensen, Terry M. Therneau, Keith D. Lindor

    Argitaratua 2000
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  18. 18
    The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years

    The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years nork Ariel E. Feldstein, Phunchai Charatcharoenwitthaya, Sombat Treeprasertsuk, Joanne T. Benson, Felicity Enders, Paul Angulo

    Argitaratua 2009
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  19. 19
    Primary Sclerosing Cholangitis in Children: A Long–Term Follow–Up Study

    Primary Sclerosing Cholangitis in Children: A Long–Term Follow–Up Study nork Ariel E. Feldstein, Jean Perrault, Mounif El-Youssif, Keith D. Lindor, Deborah K. Freese, Paul Angulo

    Argitaratua 2003
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  20. 20
    Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid

    Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid nork Paul Angulo, Roberta A. Jorgensen, Jill C. Keach, Rolland E. Dickson, Coleman Smith, Keith D. Lindor

    Argitaratua 2000
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:

Bilaketa egiteko lanabesak: